/

/

In The News

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

New kids on the block: A new generation of VCs ventures into biotech

February 27, 2025

Nvidia-backed Achira debuts, blending AI and physics to model molecules

February 21, 2025

Timmerman Report

Deepseek Shocked Silicon Valley but Its Not Earth Shaking for Biotech

February 4, 2025

Techbio VC Dimension upsizes for $500M second fund

December 12, 2024

Dimension's Zavain Dar talks about raising a $500M second fund

December 16, 2024

The 2nd Dimension: VC raises $500M fund for entrepreneurs pioneering life sci, tech

December 9, 2024

Dimension Books $500 Million for Second Life Sciences Venture Fund

December 9, 2024

Dimension raises $500M second fund for investing at the intersection tech and life sciences

December 9, 2024

Young biotech venture firm raises $500 million for its second fund

December 9, 2024

Dimension nabs $500M second fund for 'still contrary' intersection of bio and machine learning

December 9, 2024

VC Firm Dimension Raises $500 Million to Bet on AI and Medicine

December 9, 2024

BioPharma Drive

Dimension gets $500M to bankroll biotech’s convergence with tech

December 9, 2024

VC firm raises $500 million for fund aimed at intersection of tech and life sciences

December 9, 2024

Timmerman Report

Dimension Raises $500M to Seize the Tech Driven Biology Future

December 9, 2024

This is just the beginning. Make no small plans.

December 9, 2024

Announcing Dimension II

December 9, 2024

Timmerman Report

Computational Techniques Are Driving a Tidal Shift in Therapeutic Protein Design

December 5, 2024

Investing in Monte Rosa Therapeutics

Investing in Chai Discovery

September 9, 2024

GEN Biotechnology

In biotech, time is money

October 10, 2024

GEN Biotechnology

The Difference Is the Data: Drug Discovery's AI Revolution

A Conversation with Kimia’s CEO, Stig Hansen

Biocom 2024: Developing new AI capabilities (and maybe going faster, too)

February 28, 2024

The Endpoints Slack interview: Zavain Dar on starting a new VC, trusting the process with the 76ers, and Apple's VR future

February 13, 2024

Intellia and Ultragenyx’s Clinical Updates, Novo Holdings’ Catalent Acquisition, and NanoString Bankruptcy; Simon Barnett

February 9, 2024

The Generalist: Zavain Dar, GP at Dimension on investing at the bleeding edge of technology and life sciences

October 26, 2023

Dead Cat Podcast

Eric Newcomer: A New Dimension

January 31, 2023

New York Bio Breakfast Series

Homeroom Podcast

Homeroom Podcast : Adam Goulburn

Wall Street Journal

New VC Firm Dimension Gets $350 Million as Healthcare Venture Fundraising Remains High

January 26, 2023

Three venture investors weigh in on the future of biotech as they launch a new $350M fund

January 26, 2023

As Tech Giants Fall, Tech-Focused VC Fund Rakes in $350M

January 25, 2023

Creating a new dimension: Biotech VC merging tech and life sciences unveils with $350M

January 25, 2023

Three VCs launch Dimension, a new firm with plans to fuel biotech’s ‘digitization’

January 25, 2023

Focused exclusively on life sciences, three top investors set out on their own

January 25, 2023

‘Siloing is just so outdated’: New $350M VC fund aims to digitize life sciences

January 25, 2023

Timmerman Report

Dimension Debuts With 350M To Back Startups That Digitize Biology

January 25, 2023

These Venture Veterans Have Launched A $350 Million Fund Aimed At Digitizing Life Sciences

January 25, 2023